Cargando…
Clinical utility of genomic sequencing: a measurement toolkit
Whole-genome sequencing (WGS) is positioned to become one of the most robust strategies for achieving timely diagnosis of rare genomic diseases. Despite its favorable diagnostic performance compared to conventional testing strategies, routine use and reimbursement of WGS are hampered by inconsistenc...
Autores principales: | Hayeems, Robin Z., Dimmock, David, Bick, David, Belmont, John W., Green, Robert C., Lanpher, Brendan, Jobanputra, Vaidehi, Mendoza, Roberto, Kulkarni, Shashi, Grove, Megan E., Taylor, Stacie L., Ashley, Euan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738524/ https://www.ncbi.nlm.nih.gov/pubmed/33319814 http://dx.doi.org/10.1038/s41525-020-00164-7 |
Ejemplares similares
-
The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic
por: Marshall, Christian R., et al.
Publicado: (2020) -
Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease
por: Marshall, Christian R., et al.
Publicado: (2020) -
Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases
por: Bick, David, et al.
Publicado: (2019) -
Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity
por: Hayeems, Robin Z., et al.
Publicado: (2022) -
Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review
por: Hayeems, Robin Z., et al.
Publicado: (2021)